Journal article

Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus

Moritz UG Kraemer, Robert C Reiner, Oliver J Brady, Jane P Messina, Marius Gilbert, David M Pigott, Dingdong Yi, Kimberly Johnson, Lucas Earl, Laurie B Marczak, Shreya Shirude, Nicole Davis Weaver, Donal Bisanzio, T Alex Perkins, Shengjie Lai, Xin Lu, Peter Jones, Giovanini E Coelho, Roberta G Carvalho, Wim Van Bortel Show all

Nature Microbiology | NATURE PUBLISHING GROUP | Published : 2019

University of Melbourne Researchers

Grants

Awarded by Training Grant from the National Institute of Child Health and Human Development


Awarded by the International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme)


Awarded by Wellcome Trust


Awarded by Bill and Melinda Gates Foundation


Awarded by Research for Health in Humanitarian Crises (R2HC) Programme


Awarded by Bill & Melinda Gates Foundation


Awarded by US Agency for International Development Emerging Pandemic Threats Program-2 PREDICT-2


Awarded by National Library of Medicine of the National Institutes of Health


Awarded by National Institutes of Health and National Institute of Allergy and Infectious Diseases


Awarded by European Commission through the European Research Council Advanced Investigator Grant 'Momentum'


Awarded by French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases


Awarded by French Agence Nationale de la Recherche


Awarded by European Union's Horizon 2020 research and innovation programme under ZikaPLAN grant


Awarded by Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases program


Awarded by INCEPTION project


Awarded by European Union's Horizon 2020 research and innovation programme under ZIKAlliance grant


Awarded by EFSA


Awarded by National Institutes of Health


Awarded by Natural Science Foundation of China


Funding Acknowledgements

The authors thank S. Ray for providing comments during the revision process. M.U.G.K. acknowledges funding from the Society in Science, The Branco Weiss Fellowship, administered by the ETH Zurich. M.U.G.K. also acknowledges funding from the Training Grant from the National Institute of Child Health and Human Development (T32HD040128). M.U.G.K., S.I.H., J.P.M., N.G., O.J.B. and G.R.W.W. acknowledge funding from the International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme no. 21893). O.B.J. was funded by a Sir Henry Wellcome Fellowship funded by the Wellcome Trust (grant number 206471/Z/17/Z) and a grant from the Bill and Melinda Gates Foundation (OP1183567). S.I.H. received a grant from the Research for Health in Humanitarian Crises (R2HC) Programme, managed by Enhancing Learning and Research for Humanitarian Assistance (ELRHA; no. 13468), which also supported M.U.G.K. and N.G. The R2HC programme aims to improve health outcomes by strengthening the evidence base for public health interventions in humanitarian crises. The 8 million R2HC programme is funded equally by the Wellcome Trust and Department of International Development (DFiD), with ELRHA overseeing the programme's execution and management. S.I.H. was also funded by a Senior Research Fellowship from the Wellcome Trust (no. 95066) and grants from the Bill & Melinda Gates Foundation (OPP1106023, OPP1093011, OPP1132415 and OPP1159934). This study was made possible by the support of the American people through the US Agency for International Development Emerging Pandemic Threats Program-2 PREDICT-2 (Cooperative Agreement number AID-OAA-A-14-00102), which also supported M.U.G.K. J.S.B. is supported by the National Library of Medicine of the National Institutes of Health (R01LM010812 and R01LM011965), which also supports M.U.G.K. D.L.S. is funded by the National Institutes of Health and National Institute of Allergy and Infectious Diseases (no. U10AI089674). H.H.N. was funded by the European Commission through the European Research Council Advanced Investigator Grant 'Momentum' 324247. L.L. received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID), the French Agence Nationale de la Recherche (grant ANR-16-CE35-0004), the City of Paris Emergence(s) programme in Biomedical Research, and the European Union's Horizon 2020 research and innovation programme under ZikaPLAN grant agreement No. 734584. S.C. received funding from the AXA Research Fund, the Investissement d'Avenir program, the Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences, the INCEPTION project (PIA/ANR-16-CONV-0005), and the European Union's Horizon 2020 research and innovation programme under ZIKAlliance grant agreement No 734548. N.G. is supported by a University of Melbourne McKenzie fellowship. W.V.B., G.H. and F.S. acknowledge funding from VBORNET and VectorNet, an ECDC and EFSA-funded project (no. ECDC/09/018 and OC/EFSA/AHAW/2013/02), and thank all contributing VBORNET and VectorNet experts for data sharing. T.W.S., R.C.R. and L.L. received funding from the National Institutes of Health Program Project grant (no. P01 AI098670). X.L. is supported by the Natural Science Foundation of China (71771213, 71522014, 71725001, 91846301 and 71790615).This work was also partially supported by the European Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance Grant Agreement no. 734548.